ArticleClinical and translational science2024

First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.

Rupa Narayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.